Breakthrough Therapy Dabigatran Provides Consistent Benefit Across All Atrial Fibrillation Types And Stroke Risk Groups
Links shared publicly online about this topic.
- 389total visits
Breakthrough Therapy Dabigatran Provides Consistent Benefit Across All Atrial Fibrillation Types And Stroke Risk Groups
New data from two RE-LY® sub-group analyses presented today at the 60 th Annual Scientific Session of the American College of Cardiology (ACC) demonstrated that dabigatran etexilate 150mg bid
View full resource at medicalnewstoday.com
Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, Stroke, Thrombotic Event, Cardiology, Education
Most Recently Shared on April 4, 2011 at 6:23 pm By:
Breakthrough Therapy Dabigatran Provides Consistent Benefit Across All Atrial Fibrillation Types And Stroke Risk... http://bit.ly/hp8wnK
Advertisement
